FDA Approves First Nonprescription OTC Naloxone Nasal Spray; Builds on Administration’s Efforts to Improve Equitable Access to Essential Health Care
March 31, 2023 | |
FDA Approves First Nonprescription OTC Naloxone Nasal Spray; Builds on Administrationā€™s Efforts to Improve Equitable Access to Essential Health Care
The Biden-Harris Administration announced the approval of the first nonprescription, over-the-counter (OTC) naloxone nasal spray, Narcan. This action represents a significant advancement in promoting both the accessibility of naloxone, a medication that can reverse opioid-related overdoses, and equitable access to essential health care. The approval allows for the life-saving medication to be sold directly to consumers in drug stores, convenience… (Colocho, March 31, 2023) #Health Equity, #Mental and Behavioral Health, #Opioids, #Public Health
